The agreement, one of the first to share a critical Covid-19 technology, would allow the drug to be made and sold cheaply in 105 low- and middle-income countries.
The agreement, one of the first to share a critical Covid-19 technology, would allow the drug to be made and sold cheaply in 105 low- and middle-income countries.